Common Drugs Use in Ophthalmology Market size was valued at USD 25.6 Billion in 2024 and is projected to reach USD 39.1 Billion by 2033, exhibiting a CAGR of 5.2% from 2026 to 2033.
South Korea's Common Drugs Use in Ophthalmology Market: Industry Demands and Market Dynamics
In 2024, South Korea's ophthalmic drugs market generated a revenue of USD 715.3 million and is projected to reach USD 1,284.8 million by 2030, growing at a CAGR of 10.3% from 2025 to 2030. The anti-VEGF agents segment was the largest revenue-generating drug class in 2024 and is expected to continue its dominance during the forecast period.
Key Drugs in the Market:
Latanoprost: A prostaglandin analogue used to treat increased intraocular pressure in conditions like open-angle glaucoma and ocular hypertension. It works by increasing the outflow of aqueous fluid from the eyes.
Timolol: A beta-blocker used in eye drop form to treat increased pressure inside the eye, such as in ocular hypertension and glaucoma. It reduces the production of aqueous humor.
Ranibizumab: An anti-VEGF agent approved to treat wet age-related macular degeneration, diabetic retinopathy, and macular edema due to retinal vein occlusion.
Bromfenac: An NSAID used in eye drop form to treat postoperative inflammation and reduce pain in patients who have undergone cataract surgery.
Sodium Hyaluronate: Used to treat dry eye disease. The number of prescriptions increased from 39,838 in 2002 to 276,537 in 2015, with a significant rise in the use of disposable forms.
Industry Requirements:
Innovation in Drug Delivery: Development of more effective and patient-friendly drug delivery systems to enhance compliance and therapeutic outcomes.
Regulatory Compliance: Adherence to stringent regulatory standards to ensure the safety and efficacy of ophthalmic drugs.
Cost-Effectiveness: Balancing the cost of treatment with the effectiveness of drugs to make therapies accessible to a broader population.
Research and Development: Continuous investment in R&D to discover new treatments and improve existing therapies for various ophthalmic conditions.
The Common Drugs Use in Ophthalmology Market in South Korea is evolving rapidly, driven by advancements in drug formulations and a growing demand for effective eye care solutions. Industry stakeholders must focus on innovation, compliance, and cost-effectiveness to meet the increasing needs of the population.
Get an In-Depth Research Analysis of the South Korea Common Drugs Use in Ophthalmology Market Size And Forecast [2025-2032]
Pfizer
Novartis
Bausch Health
Fresenius
Teva Pharmaceutical
Allergan
Mylan
Santen Pharmaceutical
Takeda
Johnson & Johnson
APOTEX
GE Medical
Jamp Pharma
Senju Pharmaceutical
Chongqing Chemical & Pharmaceutical Holding (Group) Company
Sun Pharmaceutical
Taj Pharmaceuticals
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Common Drugs Use in Ophthalmology Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Common Drugs Use in Ophthalmology Market
Corticosteroids
NSAIDs (Non-Steroidal Anti-Inflammatory Drugs)
Immunosuppressants
Prostaglandin Analogues
Beta Blockers
Carbonic Anhydrase Inhibitors
Alpha Agonists
Rho Kinase Inhibitors
Topical Antibiotics
Oral Antibiotics
Intravitreal Antibiotics
Topical Antivirals
Systemic Antivirals
Intravitreal Antivirals
Topical Anesthetics
Regional Anesthesia
General Anesthesia
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Common Drugs Use in Ophthalmology Market Research Analysis
1. Introduction of the South Korea Common Drugs Use in Ophthalmology Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Common Drugs Use in Ophthalmology Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Common Drugs Use in Ophthalmology Market, By Type
6. South Korea Common Drugs Use in Ophthalmology Market, By Application
7. South Korea Common Drugs Use in Ophthalmology Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Common Drugs Use in Ophthalmology Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/